Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study ; volume:160 ; number:2 ; day:6 ; month:10 ; year:2016 ; pages:305-312 ; date:11.2016
Breast cancer research and treatment ; 160, Heft 2 (6.10.2016), 305-312, 11.2016
- Creator
-
Tolaney, Sara M.
- Contributor
-
Nechushtan, Hovav
Ron, Ilan-Gil
Schöffski, Patrick
Awada, Ahmad
Yasenchak, Chris A.
Laird, A. Douglas
O’Keeffe, Bridget
Shapiro, Geoffrey I.
Winer, Eric P.
SpringerLink (Online service)
- DOI
-
10.1007/s10549-016-4001-y
- URN
-
urn:nbn:de:1111-2016111332220
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tolaney, Sara M.
- Nechushtan, Hovav
- Ron, Ilan-Gil
- Schöffski, Patrick
- Awada, Ahmad
- Yasenchak, Chris A.
- Laird, A. Douglas
- O’Keeffe, Bridget
- Shapiro, Geoffrey I.
- Winer, Eric P.
- SpringerLink (Online service)
Other Objects (12)
Impact of aripiprazole discontinuation in remitted major depressive disorder: a randomized placebo-controlled trial
Cabozantinib : Cabozantinib in der Behandlung des fortgeschrittenen Nierenzellkarzinoms
Exposure–response analyses of cabozantinib in patients with metastatic renal cell cancer
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial
Population Pharmacokinetics of Cabozantinib in Metastatic Renal Cell Carcinoma Patients: Towards Drug Expenses Saving Regimens
Drug*placebo interaction effect may bias clinical trials interpretation: hybrid balanced placebo and randomized placebo-controlled design
A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients
Placebo-controlled clinical trials: how trial documents justify the use of randomisation and placebo
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study
Identification of genomic drivers for the therapeutic response of Cabozantinib in patients with metastatic renal cell carcinoma
Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
Impact of aripiprazole discontinuation in remitted major depressive disorder: a randomized placebo-controlled trial
Cabozantinib : Cabozantinib in der Behandlung des fortgeschrittenen Nierenzellkarzinoms
Exposure–response analyses of cabozantinib in patients with metastatic renal cell cancer
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial
Population Pharmacokinetics of Cabozantinib in Metastatic Renal Cell Carcinoma Patients: Towards Drug Expenses Saving Regimens
Drug*placebo interaction effect may bias clinical trials interpretation: hybrid balanced placebo and randomized placebo-controlled design
A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients
Placebo-controlled clinical trials: how trial documents justify the use of randomisation and placebo
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study
Identification of genomic drivers for the therapeutic response of Cabozantinib in patients with metastatic renal cell carcinoma
Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
Impact of aripiprazole discontinuation in remitted major depressive disorder: a randomized placebo-controlled trial
Cabozantinib : Cabozantinib in der Behandlung des fortgeschrittenen Nierenzellkarzinoms
Exposure–response analyses of cabozantinib in patients with metastatic renal cell cancer
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial
Population Pharmacokinetics of Cabozantinib in Metastatic Renal Cell Carcinoma Patients: Towards Drug Expenses Saving Regimens
Drug*placebo interaction effect may bias clinical trials interpretation: hybrid balanced placebo and randomized placebo-controlled design
A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients
Placebo-controlled clinical trials: how trial documents justify the use of randomisation and placebo
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study
Identification of genomic drivers for the therapeutic response of Cabozantinib in patients with metastatic renal cell carcinoma
Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial